AEONAEON Biopharma, Inc.同业对比
AEON Biopharma, Inc. 与SIC 2834 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AEON本股 | $13M#7 | — | — | — | — | -193.4%#8 | — | — | — | — | -67.2%#7 | — |
| MBRX | $15M#2 | 0.1x#4 | 1.3x#6 | — | — | 28.8%#3 | — | 289.6%#1 | — | — | -91.9%#10 | — |
| HIND | $14M#3 | 0.0x#1 | 5.6x#10 | 44.6x#4 | 24.4%#3 | -609.0%#12 | -3269.4%#3 | -405.7%#10 | -226.2%#4 | — | -72.9%#8 | — |
| SCNX | $14M#4 | — | 0.2x#2 | 31.9x#3 | 215.9%#2 | -404.5%#11 | -9867.9%#4 | -64.8%#4 | -73.5%#2 | 4#1 | -29.1%#4 | 108.0%#1 |
| ADIL | $14M#6 | — | — | — | — | 39.5%#2 | — | — | — | — | -40.9%#5 | — |
| PPCB | $49M#1 | 0.0x#2 | 4.9x#9 | — | — | -3136.6%#14 | — | -599.6%#11 | -533.3%#5 | — | -98.5%#12 | — |
| BIVI | $14M#5 | — | 1.3x#7 | — | — | -25.8%#7 | — | -214.9%#8 | -1671.2%#6 | — | 3.1%#1 | — |
| ASBP | $12M#8 | 0.0x#3 | 1.0x#5 | 1920.0x#5 | — | -1768.9%#13 | -312016.9%#5 | -208.2%#7 | — | — | -98.4%#11 | — |
| PHIO | $12M#9 | — | 0.9x#4 | — | -100.0%#5 | -21.7%#6 | — | -69.0%#5 | — | — | — | — |
| KPRX | $12M#10 | — | 0.7x#3 | — | -100.0%#5 | -401.4%#10 | — | -0.1%#2 | -127.6%#3 | — | -0.8%#2 | — |
| DARE | $11M#11 | — | — | 10.9x#1 | 10429.4%#1 | -230.9%#9 | -1315.5%#2 | — | — | — | -65.0%#6 | — |
| LIPO | $11M#12 | — | 7.1x#11 | 19.8x#2 | 19.3%#4 | -8.6%#5 | -947.2%#1 | -337.2%#9 | — | — | -15.4%#3 | — |
| MTVA | $10M#13 | — | 1.5x#8 | — | — | 53.0%#1 | — | -190.2%#6 | — | — | -88.9%#9 | — |
| TOVX | $10M#14 | 0.2x#5 | 0.2x#1 | — | -100.0%#5 | 7.5%#4 | — | -42.1%#3 | -51.4%#1 | — | — | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-09-16。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议